Arbutus Biopharma Corp Operating Cash Flow
Arbutus Biopharma Corp (ABUS) reported Operating Cash Flow of -$14.13 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-12
CAD
| Period end | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|
| 2012-12-31 | 33.10M CAD 20-F · filed 2013-03-27 |
| 2011-12-31 | -7.68M CAD 20-F · filed 2013-03-27 |
| 2010-12-31 | -11.25M CAD 20-F · filed 2013-03-27 |
| 2009-12-31 | -5.53M CAD 20-F · filed 2012-03-27 |
USD
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 3 month as first filed | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month | Net Cash Provided by (Used in) Operating Activities 12 month as first filed |
|---|---|---|---|---|---|---|
| 2026-06-30 | -$6.02M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | -$14.13M 10-Q · filed 2026-08-12 | -$18.81M derived: sum of 3 quarters · filed 2026-08-12 | -$24.63M derived: sum of 4 quarters · filed 2026-08-12 | ||
| 2026-03-31 | -$8.11M 10-Q · filed 2026-05-13 | -$12.79M derived: sum of 2 quarters · filed 2026-05-13 | -$18.61M derived: sum of 3 quarters · filed 2026-05-13 | -$34.36M derived: sum of 4 quarters · filed 2026-08-12 | ||
| 2025-12-31 | -$4.68M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-23 | -$10.50M derived: sum of 2 quarters · filed 2026-03-23 | -$26.25M derived: sum of 3 quarters · filed 2026-08-12 | -$39.64M 10-K · filed 2026-03-23 | ||
| 2025-09-30 | -$5.82M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$21.57M derived: sum of 2 quarters · filed 2026-08-12 | -$34.96M 10-Q · filed 2025-11-13 | -$45.27M derived: sum of 4 quarters · filed 2026-08-12 | ||
| 2025-06-30 | -$15.75M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | -$29.14M 10-Q · filed 2026-08-12 | -$39.45M derived: sum of 3 quarters · filed 2026-08-12 | -$60.19M derived: sum of 4 quarters · filed 2026-08-12 | ||
| 2025-03-31 | -$13.39M 10-Q · filed 2026-05-13 | -$23.71M derived: sum of 2 quarters · filed 2026-05-13 | -$44.44M derived: sum of 3 quarters · filed 2026-05-13 | -$58.95M derived: sum of 4 quarters · filed 2026-05-13 | ||
| 2024-12-31 | -$10.31M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-23 | -$31.05M derived: sum of 2 quarters · filed 2026-03-23 | -$45.55M derived: sum of 3 quarters · filed 2026-03-23 | -$64.85M 10-K · filed 2026-03-23 | ||
| 2024-09-30 | -$20.74M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$35.24M derived: sum of 2 quarters · filed 2025-11-13 | -$54.53M 10-Q · filed 2025-11-13 | -$71.83M derived: sum of 4 quarters · filed 2025-11-13 | ||
| 2024-06-30 | -$14.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | -$33.80M 10-Q · filed 2025-08-06 | -$51.09M derived: sum of 3 quarters · filed 2025-08-06 | -$72.88M derived: sum of 4 quarters · filed 2025-08-06 | ||
| 2024-03-31 | -$19.30M 10-Q · filed 2025-05-14 | -$36.59M derived: sum of 2 quarters · filed 2025-05-14 | -$58.37M derived: sum of 3 quarters · filed 2025-05-14 | -$77.93M derived: sum of 4 quarters · filed 2025-05-14 | ||
| 2023-12-31 | -$17.29M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | -$39.08M derived: sum of 2 quarters · filed 2025-03-27 | -$58.63M derived: sum of 3 quarters · filed 2025-03-27 | -$85.94M 10-K · filed 2025-03-27 | ||
| 2023-09-30 | -$21.78M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | -$41.34M derived: sum of 2 quarters · filed 2024-11-06 | -$68.64M 10-Q · filed 2024-11-06 | -$85.63M derived: sum of 4 quarters · filed 2024-11-06 | ||
| 2023-06-30 | -$19.56M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$46.86M 10-Q · filed 2024-08-08 | -$63.85M derived: sum of 3 quarters · filed 2024-08-08 | -$82.54M derived: sum of 4 quarters · filed 2024-08-08 | ||
| 2023-03-31 | -$27.30M 10-Q · filed 2024-05-02 | -$44.29M derived: sum of 2 quarters · filed 2024-05-02 | -$62.98M derived: sum of 3 quarters · filed 2024-05-02 | -$83.28M derived: sum of 4 quarters · filed 2024-05-02 | ||
| 2022-12-31 | -$16.99M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05 | -$35.68M derived: sum of 2 quarters · filed 2024-03-05 | -$55.98M derived: sum of 3 quarters · filed 2024-03-05 | -$35.36M 10-K · filed 2024-03-05 | ||
| 2022-09-30 | -$18.69M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | -$38.98M derived: sum of 2 quarters · filed 2023-11-07 | -$18.37M 10-Q · filed 2023-11-07 | -$37.97M derived: sum of 4 quarters · filed 2023-11-07 | ||
| 2022-06-30 | -$20.29M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $326.00K 10-Q · filed 2023-08-03 | -$19.28M derived: sum of 3 quarters · filed 2023-08-03 | -$35.32M derived: sum of 4 quarters · filed 2023-08-03 | ||
| 2022-03-31 | $20.62M 10-Q · filed 2023-05-04 | $1.01M derived: sum of 2 quarters · filed 2023-05-04 | -$15.02M derived: sum of 3 quarters · filed 2023-05-04 | -$29.03M derived: sum of 4 quarters · filed 2023-05-04 | ||
| 2021-12-31 | -$19.61M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | -$35.64M derived: sum of 2 quarters · filed 2023-03-02 | -$49.65M derived: sum of 3 quarters · filed 2023-03-02 | -$67.53M 10-K · filed 2023-03-02 | ||
| 2021-09-30 | -$16.04M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | -$30.05M derived: sum of 2 quarters · filed 2022-11-09 | -$47.93M 10-Q · filed 2022-11-09 | -$62.94M derived: sum of 4 quarters · filed 2022-11-09 | ||
| 2021-06-30 | -$14.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | -$31.89M 10-Q · filed 2022-08-04 | -$46.90M derived: sum of 3 quarters · filed 2022-08-04 | -$59.08M derived: sum of 4 quarters · filed 2022-08-04 | ||
| 2021-03-31 | -$17.88M 10-Q · filed 2022-05-05 | -$32.89M derived: sum of 2 quarters · filed 2022-05-05 | -$45.07M derived: sum of 3 quarters · filed 2022-05-05 | -$53.87M derived: sum of 4 quarters · filed 2022-05-05 | ||
| 2020-12-31 | -$15.01M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-03 | -$27.19M derived: sum of 2 quarters · filed 2022-03-03 | -$35.99M derived: sum of 3 quarters · filed 2022-03-03 | -$51.44M 10-K · filed 2022-03-03 | ||
| 2020-09-30 | -$12.17M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | -$20.98M derived: sum of 2 quarters · filed 2021-11-04 | -$36.43M 10-Q · filed 2021-11-04 | -$49.78M derived: sum of 4 quarters · filed 2021-11-04 | ||
| 2020-06-30 | -$8.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | -$24.25M 10-Q · filed 2021-08-05 | -$37.60M derived: sum of 3 quarters · filed 2021-08-05 | -$61.08M derived: sum of 4 quarters · filed 2021-08-05 | ||
| 2020-03-31 | -$15.45M 10-Q · filed 2021-05-05 | -$28.80M derived: sum of 2 quarters · filed 2021-05-05 | -$52.27M derived: sum of 3 quarters · filed 2021-05-05 | -$69.88M derived: sum of 4 quarters · filed 2021-05-05 | ||
| 2019-12-31 | -$13.35M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-04 | -$36.82M derived: sum of 2 quarters · filed 2021-03-04 | -$54.43M derived: sum of 3 quarters · filed 2021-03-04 | -$71.01M 10-K · filed 2021-03-04 | ||
| 2019-09-30 | -$23.47M 10-Q · filed 2019-11-06 | -$41.08M derived: sum of 2 quarters · filed 2019-11-06 | -$57.66M 10-Q · filed 2020-11-05 | -$74.73M derived: sum of 4 quarters · filed 2020-05-11 | ||
| 2019-06-30 | -$17.61M 10-Q · filed 2019-08-05 | -$34.19M 10-Q · filed 2020-08-07 | -$51.26M derived: sum of 3 quarters · filed 2020-05-11 | -$64.46M derived: sum of 4 quarters · filed 2020-05-11 | ||
| 2019-03-31 | -$16.58M 10-Q · filed 2020-05-11 | -$33.66M derived: sum of 2 quarters · filed 2020-05-11 | -$46.86M derived: sum of 3 quarters · filed 2020-05-11 | -$64.48M derived: sum of 4 quarters · filed 2020-05-11 | ||
| 2018-12-31 | -$17.07M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-05 | -$30.28M derived: sum of 2 quarters · filed 2020-03-05 | -$47.90M derived: sum of 3 quarters · filed 2020-03-05 | -$67.87M 10-K · filed 2020-03-05 | ||
| 2018-09-30 | -$13.20M 10-Q · filed 2019-11-06 | -$30.83M derived: sum of 2 quarters · filed 2019-11-06 | -$50.79M 10-Q · filed 2019-11-06 | -$61.13M derived: sum of 4 quarters · filed 2019-11-06 | ||
| 2018-06-30 | -$17.62M 10-Q · filed 2019-08-05 | -$37.59M 10-Q · filed 2019-08-05 | -$47.93M derived: sum of 3 quarters · filed 2019-08-05 | -$63.61M derived: sum of 4 quarters · filed 2019-08-05 | ||
| 2018-03-31 | -$19.97M 10-Q · filed 2019-05-06 | -$30.31M derived: sum of 2 quarters · filed 2019-05-06 | -$45.99M derived: sum of 3 quarters · filed 2019-05-06 | -$51.07M derived: sum of 4 quarters · filed 2019-05-06 | ||
| 2017-12-31 | -$10.34M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-07 | -$26.02M derived: sum of 2 quarters · filed 2019-03-07 | -$31.10M derived: sum of 3 quarters · filed 2019-03-07 | -$48.64M 10-K · filed 2019-03-07 | ||
| 2017-09-30 | -$15.68M 10-Q · filed 2018-11-07 | -$20.76M derived: sum of 2 quarters · filed 2018-11-07 | -$38.30M 10-Q · filed 2018-11-07 | -$53.12M derived: sum of 4 quarters · filed 2018-11-07 | ||
| 2017-06-30 | -$5.08M 10-Q · filed 2018-08-03 | -$22.62M 10-Q · filed 2018-08-03 | -$37.44M derived: sum of 3 quarters · filed 2018-08-03 | -$52.15M derived: sum of 4 quarters · filed 2018-08-03 | ||
| 2017-03-31 | -$17.54M 10-Q · filed 2018-05-04 | -$32.36M derived: sum of 2 quarters · filed 2018-05-04 | -$47.07M derived: sum of 3 quarters · filed 2018-05-04 | -$63.87M derived: sum of 4 quarters · filed 2018-05-04 | ||
| 2016-12-31 | -$14.82M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16 | -$29.53M derived: sum of 2 quarters · filed 2018-03-16 | -$46.34M derived: sum of 3 quarters · filed 2018-03-16 | -$57.88M 10-K · filed 2018-03-16 | ||
| 2016-09-30 | -$14.71M 10-Q · filed 2017-11-02 | -$31.52M derived: sum of 2 quarters · filed 2017-11-02 | -$43.06M 10-Q · filed 2017-11-02 | -$61.28M derived: sum of 4 quarters · filed 2018-03-16 | ||
| 2016-06-30 | -$16.80M 10-Q · filed 2017-08-03 | -$28.35M 10-Q · filed 2017-08-03 | -$46.56M derived: sum of 3 quarters · filed 2018-03-16 | -$49.09M derived: sum of 4 quarters · filed 2018-03-16 | ||
| 2016-03-31 | -$11.55M 10-Q · filed 2017-05-04 | -$29.76M derived: sum of 2 quarters · filed 2018-03-16 | -$32.29M derived: sum of 3 quarters · filed 2018-03-16 | -$48.96M derived: sum of 4 quarters · filed 2018-03-16 | ||
| 2015-12-31 | -$18.21M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16 | -$20.74M derived: sum of 2 quarters · filed 2018-03-16 | -$37.41M derived: sum of 3 quarters · filed 2018-03-16 | -$56.38M 10-K · filed 2018-03-16 | -$54.78M 10-K · filed 2016-03-09 | |
| 2015-09-30 | -$2.53M 10-Q · filed 2016-11-03 | -$19.20M derived: sum of 2 quarters · filed 2016-11-03 | -$38.17M 10-Q · filed 2016-11-03 | -$43.89M derived: sum of 4 quarters · filed 2017-03-22 | ||
| 2015-06-30 | -$16.67M 10-Q · filed 2016-08-04 | -$35.64M 10-Q · filed 2016-08-04 | -$41.36M derived: sum of 3 quarters · filed 2017-03-22 | -$48.08M derived: sum of 4 quarters · filed 2017-03-22 | ||
| 2015-03-31 | -$17.84M 10-Q · filed 2016-05-04 | -$24.69M derived: sum of 2 quarters · filed 2017-03-22 | -$31.41M derived: sum of 3 quarters · filed 2017-03-22 | -$39.42M derived: sum of 4 quarters · filed 2017-03-22 | ||
| 2014-12-31 | -$6.85M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-22 | -$13.57M derived: sum of 2 quarters · filed 2017-03-22 | -$21.58M derived: sum of 3 quarters · filed 2017-03-22 | -$12.42M 10-K · filed 2017-03-22 | ||
| 2014-09-30 | -$6.72M 10-Q · filed 2015-11-05 | -$14.73M derived: sum of 2 quarters · filed 2015-11-05 | -$5.58M 10-Q · filed 2015-11-05 | -$3.01M derived: sum of 4 quarters · filed 2016-03-09 | ||
| 2014-06-30 | -$8.01M 10-Q · filed 2015-08-07 | $1.15M 10-Q · filed 2015-08-07 | $3.71M derived: sum of 3 quarters · filed 2016-03-09 | $42.00K derived: sum of 4 quarters · filed 2016-03-09 | ||
| 2014-03-31 | $9.15M 10-Q · filed 2015-05-06 | $11.72M derived: sum of 2 quarters · filed 2016-03-09 | $8.05M derived: sum of 3 quarters · filed 2016-03-09 | $4.38M derived: sum of 4 quarters · filed 2016-03-09 | ||
| 2013-12-31 | $2.57M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-09 | -$1.10M derived: sum of 2 quarters · filed 2016-03-09 | -$4.77M derived: sum of 3 quarters · filed 2016-03-09 | -$6.74M 10-K · filed 2016-03-09 | -$6.74M 6-K · filed 2014-03-06 | |
| 2013-09-30 | -$3.67M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07 | -$7.34M derived: sum of 2 quarters · filed 2014-11-07 | -$9.30M 10-Q · filed 2014-11-07 | |||
| 2013-06-30 | -$3.67M 10-Q · filed 2014-11-07 | -$2.79M 10-Q · filed 2014-08-14 | -$5.63M 10-Q · filed 2014-08-14 | |||
| 2013-03-31 | -$2.84M 10-Q · filed 2014-05-14 | |||||
| 2012-12-31 | $32.91M 10-K · filed 2015-03-13 | $32.91M 6-K · filed 2014-03-06 | ||||
| 2011-12-31 | -$7.83M 10-K · filed 2014-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 |